Severity and impairment of allergic rhinitis in patients consulting in primary care.

BACKGROUND Allergic rhinitis is a disease impairing quality of life, sleep, and work. A new classification for allergic rhinitis, Allergic Rhinitis and its Impact on Asthma (ARIA), has recently been proposed. OBJECTIVE To study the effect of allergic rhinitis using ARIA definitions to determine severity and duration. METHODS A total of 3052 patients consulting general practitioners for allergic rhinitis were studied. Patients were classified according to the 4 classes of ARIA. In all patients, quality of life (Rhinoconjunctivitis Quality-of-Life Questionnaire), sleep (Jenkins questionnaire), and work performance (Allergy-Specific Work Productivity and Activity Impairment questionnaire) were assessed. RESULTS Mild intermittent rhinitis was diagnosed in 11% of the patients, mild persistent rhinitis in 8%, moderate/severe intermittent rhinitis in 35%, and moderate/severe persistent rhinitis in 46%. The severity of rhinitis has more of an effect on quality of life, sleep, daily activities, and work performance than the duration of rhinitis. In moderate/severe rhinitis, more than 80% of patients report impaired activities, as opposed to only 40% with mild rhinitis. CONCLUSION It seems that the term moderate/severe should be replaced by severe. A study in the general population is necessary, however, to assess the prevalence of the 4 ARIA classes of allergic rhinitis, especially in patients who are not consulting physicians for their symptoms.

[1]  W. Sułkowski,et al.  Assessment of smell and taste in patients with allergic rhinitis. , 2000, Acta oto-laryngologica.

[2]  International Rhinitis Management Working Group , 1994 .

[3]  H. Malmberg,et al.  Sense of smell in allergic and nonallergic rhinitis , 1998, Allergy.

[4]  S. Durham,et al.  Epidemiological characterization of the intermittent and persistent types of allergic rhinitis , 2005, Allergy.

[5]  S. Fineman,et al.  Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  B. Sibbald,et al.  Labelling of rhinitis and hayfever by doctors. , 1991, Thorax.

[7]  J Bousquet,et al.  Quality of life in allergic rhinitis and asthma. A population-based study of young adults. , 2000, American journal of respiratory and critical care medicine.

[8]  K. Olsen,et al.  Sleep and Breathing Disturbance Secondary to Nasal Obstruction , 1981, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[9]  J Bousquet,et al.  Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial , 2003, Allergy.

[10]  B. Sibbald,et al.  Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. , 1991, Thorax.

[11]  J. Mulder,et al.  The diagnosis of allergic rhinitis: how to combine the medical history with the results of radioallergosorbent tests and skin prick tests. , 1998, Scandinavian journal of primary health care.

[12]  G. Canonica,et al.  Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. , 1995, The Journal of allergy and clinical immunology.

[13]  P. Demoly,et al.  ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France , 2002, Allergy.

[14]  L. Trupin,et al.  The work impact of asthma and rhinitis: findings from a population-based survey. , 2001, Journal of clinical epidemiology.

[15]  J. Bousquet,et al.  The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies , 2002, Allergy.

[16]  C. Ellis,et al.  Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (II) , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  P. Cauwenberge,et al.  Consensus statement on the treatment of allergic rhinitis (European Academy of Allergology and Clinical Immunology) , 2001 .

[18]  E. Juniper,et al.  Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. , 1999, The Journal of allergy and clinical immunology.

[19]  R. Lockey,et al.  A three-year aerobiologic pollen survey of the Tampa Bay area, Florida. , 1991, Annals of allergy.

[20]  L. Lichtenstein,et al.  The role of ragweed pollen in autumnal asthma. , 1977, The Journal of allergy and clinical immunology.

[21]  C. Zwillich,et al.  Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. , 1998, The Journal of allergy and clinical immunology.

[22]  J Bousquet,et al.  Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.

[23]  S. Bonini,et al.  Parietaria pollinosis: a review , 1992, Allergy.

[24]  L. Lichtenstein,et al.  The role of inhalation challenge. , 1975, International archives of allergy and applied immunology.

[25]  J. Bousquet,et al.  Validation of the classification of ARIA (allergic rhinitis and its impact on asthma) , 2003, Allergy.

[26]  S. Durham,et al.  Prevalence and rate of diagnosis of allergic rhinitis in Europe , 2004, European Respiratory Journal.

[27]  J. T. Connell.  Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. , 1969, The Journal of allergy.

[28]  M. Chapman,et al.  Seasonal variation in dust mite and grass-pollen allergens in dust from the houses of patients with asthma. , 1987, The Journal of allergy and clinical immunology.

[29]  T. Casale,et al.  Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[30]  R. Rose,et al.  A scale for the estimation of sleep problems in clinical research. , 1988, Journal of clinical epidemiology.

[31]  J. Bousquet,et al.  Pilot study assessing the impact of smoking on nasal‐specific quality of life , 2004, Allergy.

[32]  J. Mulder,et al.  The Phadiatop® test compared with RAST, with the CAP system; proposal for a third Phadiatop outcome: “inconclusive” , 1994, Allergy.

[33]  J. Bousquet,et al.  Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. , 1992, The Journal of allergy and clinical immunology.

[34]  J. Bousquet,et al.  Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. , 2004, The Journal of allergy and clinical immunology.

[35]  J. Bousquet,et al.  Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.